Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Contribution of Organic Anion Transporting Polypeptide to Uptake of Its Possible Substrates into Rat Hepatocytes

Hirokazu Kouzuki, Hiroshi Suzuki, Kousei Ito, Rui Ohashi and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics February 1999, 288 (2) 627-634;
Hirokazu Kouzuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Suzuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kousei Ito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rui Ohashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichi Sugiyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Organic anion transporting polypeptide (oatp1) has been cloned from rat liver as one of the transporters responsible for the hepatic uptake of ligands, and its substrate specificity has been determined. However, the contribution of oatp1 to the Na+-independent uptake of ligands into rat hepatocytes remains to be investigated. In the present study, we determined the contribution of oatp1 and examined the uptake of ligands into primary cultured hepatocytes (cultured for 4 h) and into COS-7 cells transiently expressing oatp1 and normalized using estradiol-17β-d-glucuronide as a reference compound. Western blot analysis indicated that oatp1 was less extensively glycosylated in transfected COS-7 cells, and the expression level in transfectant was one-seventh that in rat liver. TheKm values for the uptake of estradiol-17β-d-glucuronide were similar for cultured hepatocytes and oatp1-transfected COS-7 cells (Km = 12.3 versus 20.4 μM), although theVmax value for oatp1-transfected COS-7 cells was one-seventh that for cultured hepatocytes (Vmax = 1.30 versus 0.175 nmol/min/mg protein). The contribution of oatp1 to the Na+-independent uptake of taurocholic acid and cholic acid into rat hepatocytes was more than 50 to 60%, whereas the corresponding values for the sulfate-conjugates of estrone and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole were 20 to 30%. In addition, the analysis indicated that the contribution of oatp1 to the Na+-independent uptake of several ligands [glucuronide-conjugate of 6-hydroxy-5,7-dimethyl2-methylamino-4-(3-pyridylmethyl)benzothiazole, ibuprofen, pravastatin, ouabain, and 2,4-dinitrophenyl-S-glutathione] was minimal. Collectively, the transfected COS-7 cells may be used to quantitatively predict oatp1 activity in hepatocytes after correction of its expressed amount. It is also suggested that multiple transport mechanisms are responsible for the Na+-independent uptake of organic anions into hepatocytes.

Along with renal excretion, hepatic elimination is one of the major pathways involved in the detoxification of xenobiotics. Hepatic uptake is the initial process for the elimination of xenobiotics mediated by metabolism and/or biliary excretion. Previously, the mechanism for the hepatic uptake of ligands has been studied by kinetic analysis of the experimental data obtained in vivo, in situ using perfused liver, and in vitro in isolated and/or cultured hepatocytes and isolated sinusoidal membrane vesicles (Elferink et al., 1995). Cumulative evidence indicates that organic anions such as bilirubin (Paumgartner and Reichen, 1976), bromosulfophthalein (BSP; Wolkoff et al., 1987), dibromosulfophthalein (DBSP; Blom et al., 1981), 1-anilino-8-naphthalene sulfonate (Sugiyama et al., 1983), and benzylpenicillin (Tsuji et al., 1986) are taken up by hepatocytes via a Na+-independent transport system. In addition, analysis of the hepatic uptake of bile acids revealed that the uptake of taurocholic acid (TC) and cholic acid (CA) is mediated by both Na+-dependent and -independent transport system, and approximately 20% and 60% of TC and CA uptake is mediated by a Na+-independent mechanism, respectively (Yamazaki et al., 1993b). In addition, recently, Yamazaki et al. (1993a) andNakamura et al. (1996) found that a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) and a cyclic peptide (BQ-123; an endothelin antagonist) are taken up by isolated hepatocyte via a Na+-independent transport system and reported the mutual inhibition between these compounds and DBSP or bile acids (such as TC and CA). These results are consistent with the hypothesis that Na+-independent bile acid transport and organic anion transport are mediated by a common transport carrier. Based on its wide range of substrate specificity, this putative transporter has been referred to as the “Na+-independent multispecific organic anion transporter” (Meier, 1988).

To obtain more detailed information on the mechanism of hepatic uptake, the cDNA species for Na+-TC cotransporting polypeptide (Ntcp) and organic anion transporting polypeptide (oatp1) were isolated from rat liver based on expression cloning withXenopus laevis oocytes (Hagenbuch et al., 1991; Jacquemin et al., 1994). Moreover, the human homologs of these transporters (NTCP and OATP) have been cloned (Hagenbuch and Meier, 1994; Kullak-Ublick et al., 1995). Using antibodies, in a rat liver study, it has been shown that oatp1 is selectively confined to the basolateral plasma membrane of hepatocytes (Bergwerk et al., 1996). The transport properties of oatp1 have been characterized by using oocytes injected with cRNA and mammalian cells transfected with cDNA (Meier, 1995); it has been shown that oatp1 mediates the Na+-independent uptake of TC and CA and can undergo cis-inhibition by neutral and unconjugated bile salts as well as a variety of nonbile salt amphipathic organic anions (Jacquemin et al., 1994; Kullak-Ublick et al., 1994). Moreover, it has been demonstrated that the affinity of oatp1 for estradiol 17β-d-glucuronide (E217βG; Km = 3 μM) was significantly higher than that for TC (Km = 27 μM) (Kanai et al., 1996). In addition, oatp1 has recently been demonstrated to transport anionic steroid conjugates (estrone-3-sulfate), neutral steroids (ouabain, aldosterone, cortisol), and even some amphipathic organic cations such as N-(4,4-azo-n-pentyl)-21-deoxyajmalinium, a permanently charged photolabile derivative of the antiarrhythmic drugN-propylajmaline (Bossuyt et al., 1996). Hence, oatp1 represents a polyspecific and multivalent transport system able to accept a large variety of structurally unrelated and differently charged amphipathic organic substrates.

The purpose of the present study is to examine whether several organic anions, which are taken up by hepatocytes via a Na+-independent mechanism, can be oatp1 substrates. In addition, to clarify the contribution of oatp1 to the Na+-independent uptake of ligands, we examined the uptake of ligands into primary cultured hepatocytes and into COS-7 cells transiently expressing oatp1 and normalized the uptake using E217βG as a reference compound.

Experimental Procedures

Materials.

COS-7 cells were purchased from American Type Culture Collection (Rockville, MD). [3H]E217βG (1813 GBq/mmol), [3H]TC (128.4 GBq/mmol), [3H]CA (906.5 GBq/mmol), [3H]estrone-3-sulfate (1883 GBq/mmol), and [3H]ouabain (758.5 GBq/mmol) were purchased from New England Nuclear (Boston, MA). [3H]Ibuprofen (18.5 GBq/mmol) was purchased from Amersham International (Buckinghamshire, UK). The glucuronide- and sulfate-conjugates of [14C]6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)ben-zothiazole (E3040; 1.85 GBq/mmol), prepared according to the method described previously (Hibi et al., 1994), were kindly donated by Eizai Co., Ltd (Tokyo, Japan). [3H]Pravastatin was kindly donated by Sankyo Co., Ltd (Tokyo, Japan). [3H]2,4-Dinitrophenyl-S-glutathione (DNP-SG) was synthesized according to the method described by Saxena and Henderson (1995) using [3H]glutathione (1739 GBq/mmol; New England Nuclear). All other chemicals were commercially available and of reagent grade.

Transient Expression of oatp1 cDNA in COS-7 Cells.

Full-length cDNA for oatp1, kindly donated by Dr. Peter J. Meier, was initially cloned in the plasmid pSPORT1 (BRL, Gaithersburg, MD) (Jacquemin et al., 1994). oatp1 cDNA was excised withMluI (Takara, Tokyo, Japan) to perform the subcloning into the XhoI site in the pCAGGS vector, which has an SV40 origin of replication to allow duplication of the plasmid in COS-7 cells (Niwa et al., 1991) after converting to blunt ends.

For transfection, COS-7 cells were cultured in 150-mm dishes in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum. At 30% confluence, cells were exposed to serum-free DMEM containing plasmid (1 μg/ml) and Lipofectamine (1 μg/ml; BRL, Gaithersburg, MD). At 8 h after transfection, the plasmid-Lipofectamine solution was removed, and the medium, consisting of DMEM supplemented with 5% fetal bovine serum, was cultured overnight. Then, the transfected cells were treated with trypsin and approximately 1.6 × 105 cells were seeded onto 22-mm dishes and cultured overnight. An uptake study was performed at 48 h after transfection.

Primary Cultured Rat Hepatocytes.

Rat hepatocytes were isolated from male Sprague-Dawley (SD) rats (200–250 g; Nihon Ikagaku Dobutsu Shizai Kenkyusyo, Tokyo, Japan) after perfusion of the liver with collagenase. Cell viability was routinely checked by the trypan blue [0.4% (w/v)] exclusion test. After preparation, freshly isolated cells were suspended in Williams’ medium E. Approximately 5 × 105 cells were placed onto collagen-coated 22-mm dishes and cultured for 4 h.

Northern Blot Analysis.

Northern blot analysis was performed as described previously (Ito et al., 1997). Either 0.5 or 2 μg of poly(A)+ RNA, prepared from COS-7 cells 48 h after transfection, and SD rat liver were separated on 0.8% agarose gel containing 3.7% formaldehyde and transferred to a nylon membrane, before fixation by baking for 2 h at 80°C. Blots were prehybridized in medium containing 4× saline sodium citrate (SSC), 5× Denhardt’s solution, 0.2% sodium dodecyl sulfate (SDS), 0.1 mg/ml sonicated salmon sperm DNA, and 50% formamide at 42°C for 2 h. We used 2 kbp of oatp1 cDNA (nucleic acid, 69–2102 bp) as a hybridization probe, and hybridization was performed overnight in the same buffer containing 106 cpm/ml 32P-labeled cDNA prepared by the random primed labeling method. As a control,32P-labeled cDNA for glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Clontech Laboratories, Inc., Palo Alto, CA) was used. The hybridized membrane was washed in 2× SSC and 0.1% SDS at 55°C for 20 min and then in 0.1× SSC and 0.1% SDS at 55°C for 20 min. Then, the membrane was exposed to imaging plates (Fuji Film, Tokyo, Japan) for 1 h at room temperature. The intensity of the specific band was quantified using a Bio-Image Analyzer (Bas 2000, Fuji Film).

Western Blot Analysis.

For the Western blot analysis, crude membrane was prepared from COS-7 and SD rat liver according to the method of Gant et al. (1991). Cells and liver were homogenized in five volumes of 0.1 M Tris·HCl buffer, pH 7.4, containing 1 μg/ml leupeptin and pepstain A and 50 μg/ml phenylmethylsulfonyl fluoride with 20 strokes of a Dounce homogenizer. After centrifugation (1500g for 10 min) of homogenate, the supernatant was recentrifuged (100,000g for 30 min). The precipitate was suspended in Tris·HCl buffer and recentrifuged (100,000g for 30 min). The crude membrane fraction was resuspended in the 0.1 M Tris·HCl buffer containing the proteinase inhibitors with five strokes of a Dounce homogenizer and stored at −80°C before being used for Western blot analysis. All procedures were performed at 0 to 4°C. The membrane protein concentrations were determined by the method of Lowry et al. (1951) with bovine serum albumin (BSA) as a standard. Then, either 25 or 50 μg of crude membrane was dissolved in 10 ml of 2× 0.25 M Tris·HCl buffer containing 2% SDS, 30% glycerol, and 0.01% bromophenol blue, pH 6.8, and loaded onto a 7.5% SDS-polyacrylamide gel electrophoresis plate with a 4.4% stacking gel. The molecular weight was determined using a prestained protein marker (NEB, Beverly, MA). Proteins were transferred electrophoretically to a nitrocellulose membrane (Millipore, Bedford, MA) using a blotter (BioRad Laboratories, Richmond, CA) at 15 V for 1 h. The membrane was blocked with Tris-buffered saline containing 0.05% Tween 20 (TBS-T) and 5% BSA for 1 to 2 h at room temperature. After washing with TBS-T (3× 5 min), the membrane was incubated overnight with anti-oatp1 rabbit serum (dilution 1:5000), which was kindly donated by Dr. Peter J. Meier (Bergwerk et al., 1996), in TBS-T containing 5% BSA at 4°C and then washed with TBS-T (3× 5 min). The membrane was allowed to bind to 125I-labeled sheep anti-rabbit Ig in TBS-T containing 5% BSA for 1 h at room temperature and then washed with TBS-T (3× 5 min). Then, the membrane was exposed to imaging plates (Fuji Film, Tokyo, Japan) overnight at room temperature. The intensity of the specific band was quantified using a Bio-Image Analyzer (Bas 2000, Fuji Film).

Uptake Study.

Uptake was initiated by adding the radiolabeled ligands to the medium after washing the culture dishes three times and preincubation with Krebs-Henseleit buffer or choline buffer at 37°C for 5 min. The Krebs-Henseleit buffer consisted of 142 mM NaCl, 23.8 mM Na2CO3, 4.83 mM KCl, 0.96 mM KH2PO4, 1.20 mM MgSO4, 12.5 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid, 5 mM glucose, and 1.53 mM CaCl2 adjusted to pH 7.3. The composition of the choline buffer was the same as the Krebs-Henseleit buffer except that NaCl and NaHCO3 were replaced with isotonic choline chloride and choline bicarbonate, respectively. The final concentration of [3H]E217βG, [3H]TC, [3H]CA, [3H]estrone-3-sulfate, [3H]ouabain, [3H]ibuprofen, [3H]pravastatin, and [3H]DNP-SG was 1 μM, whereas that of [14C]E3040 sulfate and [14C]E3040 glucuronide was 2 and 10 μM, respectively. At designated times, the reaction was terminated by adding ice-cold Krebs-Henseleit buffer. Just before the designated times, 50 μl of medium was transferred to scintillation vials. Then, cells were washed three times with 2 ml of ice-cold Krebs-Henseleit buffer and solubilized in 500 μl of 1 N NaOH. After adding 500 μl of distilled water, 800-μl aliquots were transferred to scintillation vials. The radioactivity associated with the cells and medium was determined in a liquid scintillation counter (LS 6000SE; Beckman Instruments, Inc., Fullerton, CA) after adding 8 ml of scintillation fluid (Hionic flow; Packard Instrument Co., Downers Grove, IL) to the scintillation vials. The remaining 100-μl aliquots of cell lyzate were used to determine protein concentrations by the method of Lowry et al. (1951) with BSA as a standard. Ligand uptake is given as the cell-to-medium concentration ratio, determined as the amount of ligands associated with the cells divided by the medium concentration.

Determination of Kinetic Parameters.

The uptake of E217βG for 1 min was studied to determine the kinetic parameters because the initial velocity of the uptake of E217βG is linear during this period. The kinetic parameters were estimated from the following equation;V0=(Vmax×S)/(Km+S) where V0 is the initial uptake velocity of E217βG (nmol/min/mg protein),S is the concentration of E217βG in the medium (μM), Km is the Michaelis constant (μM), and Vmax is the maximum uptake rate (nmol/min/mg protein). The uptake data were fitted to this equation by a nonlinear least-squares method using a MULTI program (Yamaoka et al., 1981) to obtain estimates of the kinetic parameters. The input data were weighted as the reciprocals of the squares of the observed values.

Estimation of Contribution of oatp1 to Na+-Independent Uptake of Ligands into Rat Hepatocytes.

To determine the Na+-independent uptake by hepatocytes, uptake was measured in choline buffer. oatp1-mediated uptake was determined by subtracting the uptake into COS-7 cells transfected with pCAGGS vector from that into COS-7 cells transfected with pCAGGS containing oatp1 (measured in Krebs-Henseleit buffer). The uptake clearance of ligands (CLuptake) was calculated using linear regression applied to the initial two or three data points. Rhep andRCOS were defined byRhep = CLuptakeof ligands into hepatocytes/CLuptake of E217βG into hepatocytes andRCOS = CLuptakeof ligands into COS-7 cells/CLuptake of E217βG into COS-7 cells.

The contribution of oatp1 to the Na+-independent uptake of ligands into rat hepatocytes was estimated from the following equation:Contribution (%)=Rcos/Rhep×100

Results

Expression of oatp1 in COS-7 Cells.

The expression of transfected oatp1 in COS-7 cells was examined by Northern and Western blot analyses. As shown in Fig. 1, the oatp1 transcript was found at approximately 4.3 and 2.5 kb in transfected COS-7 cells (lanes c and d), whereas it was found at approximately 4.3 kb in rat liver (lane a). However, Western blot analysis (Fig. 1) indicated that the molecular mass of the oatp1 product in COS-7 cells (lanes j and k) was approximately 72 kDa, which was significantly lower than that in liver (83 kDa) (lanes h and i). Although the amount of oatp1 transcript was approximately 10-fold higher in oatp1-transfected COS-7 cells than in liver, the amount of oatp1 expressed on the membrane prepared from oatp1-transfected COS-7 cells was approximately one-seventh that of liver (Fig. 1). No expression of oatp1 was observed in COS-7 cells transfected with pCAGGS vector (lanes f and g).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Expression of oatp1. Expression of oatp1 in transfected COS-7 cells was examined by Northern (lanes a–d) and Western (lanes e–k) blot analyses. Poly(A)+ RNA from SD rat liver and oatp1- and vector-transfected COS-7 cells were used in Northern blot analysis. The membrane hybridized with32P-labeled oatp1 cDNA fragment (nucleic acid, 69–2102 bp) and rehybridized with 32P-labeled GAPDH cDNA was exposed for 1 h at room temperature with an intensifying screen. Lanes a, b, and d were loaded with 2 μg of poly(A)+ RNA from rat liver and vector- and oatp1-transfected COS-7 cells, respectively. Lane c was loaded with 0.5 μg of poly(A)+ RNA from oatp1-transfected COS-7 cells. The crude membrane from SD rat liver and oatp1- and vector-transfected COS-7 cells were used in Western blot analysis. The membrane incubated with anti-rabbit oatp1 serum was exposed overnight at room temperature with an intensifying screen. Lanes e, f, g, h, i, j, and k were loaded with a marker, 50 and 25 μg of crude membrane from vector-transfected COS-7 cells, 50 and 25 μg of crude membrane from liver, and 50 and 25 μg of crude membrane from oatp1-transfected COS-7 cells, respectively.

Quantification of Ligand Transport.

Na+-independent uptake of E217βG, TC, CA, estrone-3-sulfate, and E3040 sulfate was observed in rat hepatocytes (Fig. 2). In addition, the uptake of these ligands into COS-7 cells was stimulated by transfection of oatp1 (Fig. 2). Kinetic analysis of the Na+-independent uptake of E217βG by cultured hepatocytes gave aKm of 12.9 ± 1.3 μM and aVmax of 1.30 ± 0.10 nmol/min/mg protein (Fig. 3). In the same manner, theKm and Vmax of oatp1-mediated E217βG uptake was 20.4 ± 9.0 μM and 0.175 ± 0.051 nmol/min/mg protein, respectively (Fig. 3).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Time profiles for the uptake of ligands by primary cultured hepatocytes and oatp1-transfected COS-7 cells. Uptake of E217βG (1 μM), TC (1 μM), CA (1 μM), estrone-3-sulfate (estrone sulfate; 1 μM), and E3040 sulfate (2 μM) by primary cultured hepatocytes (top) and oatp1-transfected COS-7 cells (bottom) was examined. For experiments in COS-7 cells, ○ and • represent the uptake into vector- and oatp1-transfected COS-7 cells, respectively. Dotted lines represent the oatp1-mediated uptake, which was determined as the differences in the uptake between oatp1- and vector-transfected cells. Each symbol and vertical bar represents the mean ± S.E. of determinations. The number of the determinations of the uptake of E217βG, TC, CA, estrone sulfate, and E3040 sulfate by hepatocytes were 30, 33, 9, 6, and 9 in 10, 11, 3, 2, and 3 independent preparations, respectively. The number of the determinations of the uptake of E217βG, TC, CA, estrone sulfate, and E3040 sulfate by COS-7 cells were 9, 9, 6, 6, and 6 in 3, 3, 2, 2, and 2 independent preparations, respectively.

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

Saturation of the Na+-independent and oatp1-mediated uptake of E217βG. Saturation of the Na+-independent uptake of E217βG by primary cultured hepatocytes was determined in the absence of Na+(left). oatp1-mediated uptake of E217βG by transfected COS-7 cells was determined as the differences in the uptake between oatp1- and vector-transfected COS-7 cells (right). Each symbol and vertical bar represents the mean ± S.E. of three independent determinations.

The CLuptake for the Na+-independent uptake of E217βG, TC, CA, estrone-3-sulfate, and E3040 sulfate by cultured hepatocytes was 63, 13, 40, 78, and 29 μl/min/mg protein, respectively (Table 1). In the same manner, the oatp1-mediatedCLuptake of E217βG, TC, CA, estrone-3-sulfate, and E3040 sulfate was calculated to be 19, 2.3, 6.2, 6.3, and 1.8 μl/min/mg protein, respectively (Table 1). These results gaveRhep andRCOS values of 0.2 and 0.12 for TC, 0.63 and 0.33 for CA, 1.2 and 0.33 for estrone-3-sulfate, and 0.46 and 0.095 for E3040 sulfate, respectively (Table 1). The contribution of oatp1 to the Na+-independent uptake of TC, CA, estrone-3-sulfate, and E3040 sulfate into cultured hepatocytes was 60%, 52%, 27%, and 21%, respectively (Table 1).

View this table:
  • View inline
  • View popup
Table 1

Contribution of oatp1 to Na+-independent uptake of ligands into rat hepatocytes

Transfection of oatp1 did not affect the uptake of E3040 glucuronide, ibuprofen, pravastatin, DNP-SG, and ouabain by COS-7 cells (Fig.4), although the Na+-independent uptake of these ligands into rat hepatocytes was observed. Accordingly, the contribution of oatp1 to the uptake of these ligands into hepatocytes was minimal (Table 1).

Figure 4
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4

Time profiles for the uptake of ligands by primary cultured hepatocytes and oatp1-transfected COS-7 cells. Uptake of ibuprofen (1 μM), pravastatin (1 μM), ouabain (1 μM), DNP-SG (1 μM), and E3040 glucuronide (10 μM) by primary cultured hepatocytes (top) and oatp1-transfected COS-7 cells (bottom) was examined. For experiments in COS-7 cells, ○ and • represent the uptake into vector- and oatp1-transfected COS-7 cells, respectively. Each symbol and vertical bar represents the mean ± S.E. of determinations. The number of the determinations of the uptake of ibuprofen, pravastatin, ouabain, DNP-SG, and E3040 glucuronide by hepatocytes were 9, 9, 9, 3, and 3 in 3, 3, 3, 1, and 1 independent preparations, respectively. The number of the determinations of the uptake of ibuprofen, pravastatin, ouabain, DNP-SG, and E3040 glucuronide by COS-7 cells were 6, 9, 6, 3, and 3 in 2, 3, 2, 1, and 1 independent preparations, respectively.

Discussion

In the present study, we compared the ligand transport between primary cultured rat hepatocytes and oatp1-transfected COS-7 cells. Because it has been reported that the expression of transporters and their function is reduced in hepatocytes cultured for more than 6 h (Ishigami et al., 1995; Liang et al., 1993), the culture period was restricted to 4 h or less in the present study (Torchia et al., 1996).

The expression of oatp1 cDNA was studied in transfected COS-7 cells (Fig. 1). Northern blot analysis indicated that the length of the transcript (approximately 4.3 and 2.5 kb; Fig. 1) was similar to that observed in liver (approximately 4.3 kb; Fig. 1), which is in agreement with previous reports. Jacquemin et al. (1994) reported that oatp1 cDNA hybridized with several mRNAs from rat liver (4.3, 3.3, 2.5, and 1.4 kb), and the strongest hybridization signal was observed with mRNA of 4.3 and 3.3 kb. In addition, Bergwerk et al. (1996) indicated that oatp1 cDNA hybridized with RNA of 4.3 and 3.3 kb isolated from rat liver by Northern blot analysis under high-stringency conditions. Western blot analysis indicated that the molecular mass of oatp1 expressed in COS-7 cells (approximately 72 kDa; Fig. 1) was smaller than that in rat liver (approximately 83 kDa; Fig. 1). This lower molecular mass of oatp1 in the transfected COS-7 cells may be accounted for by a much lower degree of glycosylation of this transporter; previous Western blot analysis indicated that the molecular mass of oatp1 in rat liver was 80 kDa and that in oatp1-transfected HeLa cells with vaccinia virus was 70 kDa. In addition, preincubation of rat sinusoidal membrane subfractions with N-glycanase resulted in a shift of oatp1 migration from 80 to 65 kDa (Bergwerk et al., 1996). Collectively, the results of the present study may be accounted for if the glycosylation of oatp1 in transfected COS-7 cells is minimal. In our previous study, Western blot analysis indicated that the molecular mass of Ntcp expressed in COS-7 cells (approximately 33 kDa) was also much smaller than that in cultured hepatocytes (approximately 51 kDa), which may be due to the lower degree of glycosylation (Kouzuki et al., 1998). As shown in Fig. 1, we found that although the mRNA levels in COS-7 cells are approximately 10-fold higher than that in liver, the expression of oatp1 in oatp1-transfected COS-7 cells is approximately one-seventh that in liver. Such a difference in the expression level between mRNA and protein has been observed frequently. The results can be accounted for by low efficiency of transcription in COS-7 cells and/or by less stability of oatp1 protein in COS-7 cells. The latter explanation is also plausible because 1) we found that oatp1 product in COS-7 cells was less glycosylated and 2) it has been demonstrated that less glycosylation results in the instability of proteins (Schinkel et al., 1993). These results are also consistent with the expression of Ntcp in the transfected COS-7 cells (Kouzuki et al., 1998).

Our kinetic analysis indicated that theKm value for E217βG was similar in cultured hepatocytes and oatp1-transfected COS-7 cells (12.9 versus 20.4 μM), although the deviation was associated with the data (Fig. 3). These values are in agreement with previous reports in which theKm of oatp1 for E217βG was examined in cRNA-injected oocytes (3 μM) (Bossuyt et al., 1996), in cDNA-transfected HeLa cells with vaccinia virus (3.2 μM) (Kanai et al., 1996), and in sinusoidal membrane vesicles isolated from rat liver (4.5–13 μM) (Brouwer et al., 1987, Vore and Hoffman, 1994). We found that theVmax for E217βG in oatp1-transfected COS-7 cells was approximately one-seventh that in hepatocytes (1.30 versus 0.175 nmol/min/mg protein) (Fig. 3). Because the Western blot analysis revealed that the expression of oatp1 in the transfected COS-7 cells is one-seventh that in the liver after correction of the background level (Fig. 1), this suggested that the glycosylation of oatp1 may have no affect on either the affinity or the velocity of transport. In addition, the transfected COS-7 cells may be used to quantitatively predict oatp1-activity in hepatocytes after correction of its expressed amount by Western blot analysis.

Using oatp1-transfected cells, we showed that TC, CA, estrone-3-sulfate, and E3040 sulfate are substrates for oatp1 (Fig. 2). These results are consistent with previous works; Jacquemin et al. (1994) and Bossuyt et al. (1996) found that injection of oatp1 cRNA into oocytes stimulated the uptake of TC, CA and estrone-3-sulfate.Kanai et al. (1996) demonstrated that theCLuptake of TC into oatp1-transfected HeLa cells with vaccinia virus was approximately 6-fold lower than that of E217βG (0.53 versus 3.1 μl/min/mg protein), which is comparable with the present observation; in oatp1-transfected COS-7 cells,CLuptake of TC was approximately 8-fold lower than that of E217βG (2.3 versus 19 μl/min/mg protein; Table 1). By using E217βG as a reference compound, we could determine the contribution of oatp1 to the hepatic uptake of ligands. Our kinetic analysis indicated that 50 to 60% of the Na+-independent hepatic uptake of TC and CA is accounted for by oatp1 (Table 1). Because it has been shown that approximately 65% and 70% of hepatocellular uptake of TC and CA in the absence of Na+ are accounted for by a saturable processes (Yamazaki et al., 1993b), the contribution of oatp1 to the Na+-independent specific uptake of these bile acids may be higher than 50 to 60%. In contrast, oatp1 contributed approximately 27% and 21% to the Na+-independent uptake of estrone-3-sulfate and E3040 sulfate, respectively (Table 1), suggesting that another transporter(s) may be involved in the Na+-independent uptake of these ligands. For E3040 sulfate, more than 80% of Na+-independent hepatocellular uptake was accounted for by a carrier-mediated mechanism (Takenaka et al., 1997).

We also examined the uptake of E3040 glucuronide, ibuprofen, pravastatin, DNP-SG, and ouabain in oatp1-transfected COS-7 cells. Although these ligands were taken up by the cultured hepatocytes, and indeed, the contribution of carrier-mediated uptake has been determined as more than 80% for E3040 glucuronide, pravastatin, and ouabain (Eaton and Klaassen, 1978; Takenaka et al., 1997; Yamazaki et al., 1993a), transfection of oatp1 did not stimulate the uptake into COS-7 cells (Fig. 4). Some of the present results are inconsistent with previously accepted ideas; we demonstrated that the hepatic uptake of pravastatin is mediated by a Na+-independent mechanism and that the uptake is competitively inhibited by DBSP and bile acids (such as TC and CA; Yamazaki et al., 1993a). These results are consistent with the hypothesis that the hepatic uptake of pravastatin is mediated by a “multispecific organic anion transporter” (Meier, 1988). The results of the present study, however, indicate that oatp1 does not predominantly mediate the transport of pravastatin (Table 1). It is therefore necessary to assume the presence of multiple transporters to provide a molecular basis for the concept that the hepatic uptake of organic anions is mediated by a multispecific organic anion transporter, which has been established from a kinetic analysis of the experimented data obtained in isolated/cultured hepatocytes and isolated sinusoidal membrane vesicles (Meier, 1988). It is plausible that oatp2, a homolog of oatp1, may also responsible for the hepatic uptake of organic anions (Noe et al., 1997). Such inconsistency in the observations between the hepatocytes and gene product has been reported previously; although mutual competitive inhibition is observed between TC and bumetanide in hepatocytes (Blitzer et al., 1982; Petzinger et al., 1989), Ntcp dose not mediate the Na+-dependent uptake of bumetanide (Petzinger et al., 1996).

Although Bossuyt et al. (1996) demonstrated that injection of oatp1 cRNA into oocytes stimulated the uptake of ouabain, we found that transfection of oatp1 cDNA did not affect the uptake of this compound into COS-7 cells. This discrepancy may be accounted for by considering the background level of uptake in COS-7 cells. TheCLuptake of E217βG and ouabain into oocytes injected with oatp1 cRNA was approximately 9.7 and 0.21 nl/min/oocyte, respectively (Bossuyt et al., 1996). If the uptake of ouabain is mediated by oatp1 in the transfected COS-7 cells, theCLuptake of ouabain is calculated to be 0.41 μl/min/mg protein from that of E217βG (19 μl/min/mg protein; Table 1), whereas that of ouabain into vector-transfected COS-7 cells was 1.8 μl/min/mg protein (Fig. 4). It is possible that the background level of uptake in COS-7 cells prevented detection of the oatp1-mediated transport of ouabain. Because it was recently demonstrated that oatp2 mediates the uptake of ouabain, the contribution of oatp2 to the hepatic uptake of the cardiac glycoside may be predominant (Noe et al., 1997).

The limitation of the present method to determine quantitatively the contribution of oatp1 to the hepatic uptake of substrates is related to the assumption that E217βG is predominantly taken up by hepatocytes via oatp1. However, Brouwer et al. (1987)indicated that at least two transport systems are involved in the hepatocellular uptake of E217βG (kinetic parameters: Km1 = 4.54 μM;Vmax1 = 0.149 nmol/min/mg protein;Km2 = 149 μM;Vmax2 = 0.641 nmol/min/mg protein). More recently, oatp2 has been cloned from rat brain as a homolog of oatp1. Indeed, oatp2 is also expressed in hepatocytes and accepts E217βG as the substrate (Noe et al., 1997). Collectively, we must be cautious in the interpretation of the data because the magnitude of the contribution of oatp1 may be overestimated if other identified or unidentified membrane protein or proteins are responsible for the hepatic uptake of E217βG. Although it was suggested that the uptake of E217βG by hepatocytes is predominantly mediated by oatp1 based on the agreement in theVmax value for the uptake of E217βG and the expression level of oatp1 protein between hepatocytes and transfected COS-7 cells, a full answer to this question may be obtained by investigation of the effect of antisense against oatp1 on the uptake of E217βG by oocytes given an injection of total rat liver mRNA. No such experiment has been performed for E217βG, whereas it was shown that the simultaneous injection of antisense against oatp1 with total liver mRNA into the oocytes resulted in a reduction in the Na+-independent uptake of TC and BSP by 80% and 50%, respectively (Hagenbuch et al., 1996). Regardless of the limitation, the use of the present method should be still meaningful because we could demonstrate the role of additional transporters for the Na+-independent hepatic uptake of estrone-3-sulfate, E3040 sulfate, E3040 glucuronide, ibuprofen, pravastatin, DNP-SG, and ouabain.

In conclusion, a comparison of the uptake by rat hepatocytes and oatp1-transfected COS-7 cells suggested that more than 50 to 60% of the Na+-independent uptake of TC and CA is mediated by oatp1, whereas oatp1 accounted for only 20 to 30% of the Na+-independent uptake of estrone-3-sulfate and E3040 sulfate. In addition, the contribution of oatp1 to the uptake of E3040 glucuronide, ibuprofen, pravastatin, DNP-SG, and ouabain was minimal, suggesting the presence of multispecificity for the Na+-independent transport mechanism across the sinusoidal membrane.

Acknowledgments

We would like to thank Eizai Co., Ltd., for providing labeled and unlabeled sulfate- and glucuronide-conjugate of E3040; Sankyo Co., Ltd., for providing labeled and unlabeled pravastatin; and Dr. Peter J. Meier for providing oatp1 cDNA and anti-oatp1 rabbit serum.

Footnotes

  • Send reprint requests to: Yuichi Sugiyama, Ph.D., Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

  • ↵1 This work was supported in part by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan, and the Core Research for Evolutional Sciences and Technology of Japan Sciences and Technology Corporation.

  • Abbreviations:
    Ntcp
    sodium taurocholate cotransporting polypeptide
    oatp
    organic anion transporting polypeptide
    E217βG
    estradiol-17βd-glucuronide
    TC
    taurocholate, taurocholic acid
    CA
    cholate, cholic acid
    DNP-SG
    2,4-dinitrophenyl-S-glutathione
    E3040
    6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole
    BSP
    bromosulfophthalein
    DBSP
    dibromosulfophthalein
    DMEM
    Dulbecco’s modified Eagle’s medium
    SSC
    saline sodium citrate
    SDS
    sodium dodecyl sulfate
    BSA
    bovine serum albumin
    TBS-T
    Tris-buffered saline containing 0.05% Tween 20
    SD
    Sprague-Dawley
    Km
    Michaelis constant
    Vmax
    maximum transport velocity
    CLuptake
    uptake clearance
    • Received March 11, 1998.
    • Accepted August 31, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    1. Bergwerk AJ,
    2. Shi X,
    3. Ford AC,
    4. Kanai N,
    5. Jacquemin E,
    6. Burk RD,
    7. Bai S,
    8. Novikoff PM,
    9. Stieger B,
    10. Meier PJ,
    11. Schuster VL,
    12. Wolkoff AW
    (1996) Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am J Physiol 271:G231–G238.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Blitzer BL,
    2. Ratoosh SL,
    3. Donovan CB,
    4. Boyer JL
    (1982) Effects of inhibitors of Na+-coupled ion transport on bile acid uptake by isolated rat hepatocytes. Am J Physiol 243:G48–G53.
    OpenUrlFREE Full Text
  3. ↵
    1. Blom A,
    2. Keulemans K,
    3. Meijer DKF
    (1981) Transport of dibromosulphthalein by isolated rat hepatocytes. Biochem Pharmacol 30:1809–1816.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Bossuyt X,
    2. Müller M,
    3. Hagenbuch B,
    4. Meier PJ
    (1996) Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver. J Pharmacol Exp Ther 276:891–896.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Brouwer KLR,
    2. Durham S,
    3. Vore M
    (1987) Multiple carriers for uptake of [3H]estradiol 17β(β-D-glucuronide) in isolated rat hepatocytes. Mol Pharmacol 32:519–523.
    OpenUrlAbstract
  6. ↵
    1. Eaton DL,
    2. Klaassen CD
    (1978) Carrier-mediated transport of ouabain in isolated hepatocytes. J Pharmacol Exp Ther 205:480–488.
    OpenUrlFREE Full Text
  7. ↵
    1. Elferink RPJO,
    2. Meijer DKF,
    3. Kuipers F,
    4. Jansen PLM,
    5. Groen AK,
    6. Groothuis GMM
    (1995) Hepatobiliary secretion of organic compounds: Molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215–268.
    OpenUrlPubMed
  8. ↵
    1. Gant TW,
    2. Silverman JA,
    3. Bisgaard HC,
    4. Burt RK,
    5. Marino PA,
    6. Thorgeirsson SS
    (1991) Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P4501A gene family expression in primary hepatocyte cultures and rat liver. Mol Carcinogen 4:499–509.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Hagenbuch B,
    2. Stieger B,
    3. Foguet M,
    4. Lübbert H,
    5. Meier PJ
    (1991) Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sci USA 88:10629–10633.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Hagenbuch B,
    2. Meier PJ
    (1994) Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 93:1326–1331.
  11. ↵
    1. Hagenbuch B,
    2. Scharschmidt BF,
    3. Meier PJ
    (1996) Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem J 316:901–904.
  12. ↵
    1. Hibi S,
    2. Okamoto Y,
    3. Tagami K,
    4. Numata H,
    5. Kobayashi N,
    6. Shinoda M,
    7. Kawahara T,
    8. Murakami M,
    9. Oketani K,
    10. Inoue T,
    11. Shibata H,
    12. Yamatsu I
    (1994) Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: Synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives. J Med Chem 37:3062–3070.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Ishigami M,
    2. Tokui T,
    3. Komai T,
    4. Tsukahara K,
    5. Yamazaki M,
    6. Sugiyama Y
    (1995) Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes. Pharm Res 12:1741–1745.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Ito K,
    2. Suzuki H,
    3. Hirohashi T,
    4. Kume K,
    5. Shimizu T,
    6. Sugiyama Y
    (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 272:G16–G22.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Jacquemin E,
    2. Hagenbuch B,
    3. Stieger B,
    4. Wolkoff AW,
    5. Meier PJ
    (1994) Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA 91:133–137.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Kanai N,
    2. Lu R,
    3. Bao Y,
    4. Wolkoff AW,
    5. Vore M,
    6. Schuster VL
    (1996) Estradiol 17β-D-glucuronide is a high-affinity substrate for oatp organic anion transporter. Am J Physiol 270:F326–F331.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Kouzuki H,
    2. Suzuki H,
    3. Ohashi R,
    4. Ito K,
    5. Sugiyama Y
    (1998) Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes. J Pharmacol Exp Ther 286:1043–1050.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Kullak-Ublick GA,
    2. Hagenbuch B,
    3. Stieger B,
    4. Wolkoff AW,
    5. Meier PJ
    (1994) Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 20:411–416.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Kullak-Ublick GA,
    2. Hagenbuch B,
    3. Stieger B,
    4. Schteingart CD,
    5. Hofmann AF,
    6. Wolkoff AW,
    7. Meier PJ
    (1995) Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109:1274–1282.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Liang D,
    2. Hagenbuch B,
    3. Stieger B,
    4. Meier PJ
    (1993) Parallel decrease of Na+-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology 18:1162–1166.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Lowry OH,
    2. Rosebrough NJ,
    3. Farr AL,
    4. Randall RJ
    (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275.
    OpenUrlFREE Full Text
  22. ↵
    1. Meier PJ
    (1988) Transport polarity of hepatocytes. Semin Liver Dis 8:293–307.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Meier PJ
    (1995) Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol 269:G801–G812.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Nakamura T,
    2. Hisaka A,
    3. Sawasaki Y,
    4. Suzuki Y,
    5. Fukami T,
    6. Ishikawa K,
    7. Yano M,
    8. Sugiyama Y
    (1996) Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes. J Pharmacol Exp Ther 278:564–572.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Niwa H,
    2. Yamamura K,
    3. Miyazaki J
    (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–200.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Noe B,
    2. Hagenbuch B,
    3. Stieger B,
    4. Meier PJ
    (1997) Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA 94:10346–10350.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Paumgartner G,
    2. Reichen J
    (1976) Kinetics of hepatic uptake of unconjugated bilirubin. Clin Sci Mol Med 51:169–176.
    OpenUrlPubMed
  28. ↵
    1. Petzinger E,
    2. Müller N,
    3. Föllmann W,
    4. Deutscher J,
    5. Kinne RKH
    (1989) Uptake of bumetanide into isolated rat hepatocytes and primary liver cell cultures. Am J Physiol 256:G78–G86.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Petzinger E,
    2. Blumrich M,
    3. Bruhl B,
    4. Eckhardt U,
    5. Föllmann W,
    6. Honscha W,
    7. Horz JA,
    8. Muller N,
    9. Nickau L,
    10. Ottallah-Kolac M,
    11. Platte HD,
    12. Schenk A,
    13. Schuh K,
    14. Schulz K,
    15. Schulz S
    (1996) What we have learned about bumetanide and the concept of multispecific bile acid/drug transporters from the liver. J Hepatol 24:42–46.
  30. ↵
    1. Saxena M,
    2. Henderson GB
    (1995) ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. J Biol Chem 270:5312–5319.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Schinkel AH,
    2. Kemp S,
    3. Dolle M,
    4. Rudenko G,
    5. Wagenaar E
    (1993) N-Glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J Biol Chem 268:7477–7481.
    OpenUrl
  32. ↵
    1. Sugiyama Y,
    2. Kimura S,
    3. Lin JH,
    4. Izukura M,
    5. Awazu S,
    6. Hanano M
    (1983) Effects of organic anions on the uptake of 1-anilino-8-naphthalenesulfonate by isolated liver cells. J Pharm Sci 72:871–876.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Takenaka O,
    2. Horie T,
    3. Suzuki H,
    4. Sugiyama Y
    (1997) Carrier-mediated active transport of the glucuronide and sulfate of 6-hydoxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole (E3040) into rat liver: Quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo. J Pharmacol Exp Ther 280:948–958.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Torchia EC,
    2. Shapiro RJ,
    3. Agellon LB
    (1996) Reconstitution of bile acid transport in the rat hepatoma McArdle RH-7777 cell line. Hepatology 24:206–211.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Tsuji A,
    2. Terasaki T,
    3. Takanosu K,
    4. Tamai I,
    5. Nakashima E
    (1986) Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Biochem Pharmacol 35:151–158.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Vore M,
    2. Hoffman T
    (1994) Carrier-mediated electrogenic transport of estradiol-17β-glucuronide in rat liver BMV. Am J Physiol 267:G546–G551.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Wolkoff AW,
    2. Samuelson AC,
    3. Johansen KL,
    4. Nakata R,
    5. Withers DM,
    6. Sosiak A
    (1987) Influence of Cl− on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest 79:1259–1268.
  38. ↵
    1. Yamaoka K,
    2. Tanigawara Y,
    3. Nakagawa T,
    4. Uno T
    (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobio-Dyn 4:879–885.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Yamazaki M,
    2. Suzuki H,
    3. Hanano M,
    4. Tukui T,
    5. Komai T,
    6. Sugiyama Y
    (1993a) Na+-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 264:G36–G44.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Yamazaki M,
    2. Suzuki H,
    3. Hanano M,
    4. Sugiyama Y
    (1993b) Different relationships between cellular ATP and hepatic uptake among taurocholate, cholate, and organic anions. Am J Physiol 264:G693–G701.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 288 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 288, Issue 2
1 Feb 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of Organic Anion Transporting Polypeptide to Uptake of Its Possible Substrates into Rat Hepatocytes
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Contribution of Organic Anion Transporting Polypeptide to Uptake of Its Possible Substrates into Rat Hepatocytes

Hirokazu Kouzuki, Hiroshi Suzuki, Kousei Ito, Rui Ohashi and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics February 1, 1999, 288 (2) 627-634;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Contribution of Organic Anion Transporting Polypeptide to Uptake of Its Possible Substrates into Rat Hepatocytes

Hirokazu Kouzuki, Hiroshi Suzuki, Kousei Ito, Rui Ohashi and Yuichi Sugiyama
Journal of Pharmacology and Experimental Therapeutics February 1, 1999, 288 (2) 627-634;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Pharmacological Characterization of Nicotine-Induced Seizures in Mice
  • Streptococcus pneumoniae Pneumonia in Mice: Optimal Amoxicillin Dosing Predicted from a Pharmacokinetic-Pharmacodynamic Model
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics